Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in ME/CFS
2014-004029-41Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cyclophosphamide in myalgic encephalomyelitis (ME), sponsored by Haukeland University Hospital. Primary endpoint: Change in self-reported Fatigue score. Started Oct 2014; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on 2014-004029-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004029-41.